These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 19796900

  • 1. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H.
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [Abstract] [Full Text] [Related]

  • 2. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG, Ai V, Chan JK, Li KW, Cheung PS, Wong TT, Ma M, Lee R, Chien D.
    J Comput Assist Tomogr; 2009 Nov; 33(1):63-9. PubMed ID: 19188787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T, Isomoto I, Sueyoshi E, Yano H, Uga T, Abe K, Hayashi T, Honda S, Yamaguchi T, Uetani M.
    Magn Reson Med Sci; 2010 Nov; 9(4):217-25. PubMed ID: 21187691
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
    Tozaki M, Fukuma E.
    AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
    [Abstract] [Full Text] [Related]

  • 9. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
    Yoo H, Shin HJ, Baek S, Cha JH, Kim H, Chae EY, Kim HH.
    Magn Reson Imaging; 2014 Sep; 32(7):867-74. PubMed ID: 24907855
    [Abstract] [Full Text] [Related]

  • 11. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL, Rahmat K, Rozalli FI, Mohd-Shah MN, Aziz YF, Yip CH, Vijayananthan A, Ng KH.
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M, Ito H, Akazawa K, Kubota T, Kizu O, Yamada K, Nishimura T.
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [Abstract] [Full Text] [Related]

  • 13. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G, Topal U, Yildirim N, Tolunay S.
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.
    Jang KM, Kim SH, Hwang J, Lee SJ, Kang TW, Lee MW, Choi D.
    AJR Am J Roentgenol; 2014 Oct; 203(4):803-12. PubMed ID: 25247945
    [Abstract] [Full Text] [Related]

  • 15. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS, Tse GM, Lai SY, Yeung DK.
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [Abstract] [Full Text] [Related]

  • 16. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N.
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Breast diffusion-weighted MRI: comparison of tetrahedral versus orthogonal diffusion sensitization for detection and localization of mass lesions.
    Ueguchi T, Yamada S, Mihara N, Koyama Y, Sumikawa H, Tomiyama N.
    J Magn Reson Imaging; 2011 Jun; 33(6):1375-81. PubMed ID: 21591006
    [Abstract] [Full Text] [Related]

  • 19. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions.
    Ouyang Z, Ouyang Y, Zhu M, Lu Y, Zhang Z, Shi J, Li X, Ren G.
    Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698
    [Abstract] [Full Text] [Related]

  • 20. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.